{"id":"W2040291607","doi":"10.1038/sj.bjc.6605243","title":"CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"ca_institutions":"CancerCare Manitoba; St. Boniface Hospital","funders":"Pfizer","keywords":"Gemcitabine; Medicine; Axitinib; Internal medicine; Pancreatic cancer; Biomarker; Oncology; Gastroenterology; Population; Confidence interval; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002262198,0.0006181823,0.00195233,0.0003795544,0.0002104064,0.0009184635,0.0004709532,0.00121499,0.002353746],"category_scores_gemma":[0.002708836,0.0003855487,0.001984102,0.0004858308,0.0006527842,0.000792174,0.000649291,0.001668717,0.0002381738],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000774155,"about_ca_system_score_gemma":0.0007324803,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006264001,"about_ca_topic_score_gemma":0.0007836635,"domain_scores_codex":[0.998744,0.0006992675,0.00009500389,0.0002015295,0.00008751917,0.0001726175],"domain_scores_gemma":[0.9982464,0.0005500233,0.0004683836,0.00007659318,0.00005612089,0.0006024095],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9702486,0.001106026,0.01894453,0.0001559844,0.001118808,0.00003511833,0.00004583474,0.0004354919,0.001286476,0.0000381023,0.0002181613,0.006366887],"study_design_scores_gemma":[0.3711867,0.4391097,0.1752821,0.0001300611,0.005287677,0.0001953106,0.0001572327,0.003896935,0.001779623,0.0006627901,0.002238415,0.0000734773],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965576,0.002154371,0.0001197121,0.0001785223,0.0001325475,0.00024564,0.0001822095,0.000007120767,0.0004223835],"genre_scores_gemma":[0.9980039,0.0004460993,0.0001762251,0.0002002705,0.0001218658,0.0003879635,0.00027996,0.000002405371,0.0003814258],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002353746,"threshold_uncertainty_score":0.01196384,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02325453379314503,"score_gpt":0.3661477160749084,"score_spread":0.3428931822817634,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}